(Q37269872)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19050195%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

0 references

1 reference

title

Clinical equivalence of generic and brand-name drugs used in cardiovascular disease: a systematic review and meta-analysis (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19050195%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

main subject

meta-analysis

0 references

cardiovascular disease

1 reference

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19050195%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

Joy L Lee

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19050195%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

7

William H Shrank

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19050195%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

6

Niteesh K Choudhry

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19050195%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

5

M Alan Brookhart

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19050195%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

2

Alexander S Misono

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19050195%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

author name string

Margaret R Stedman

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19050195%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

language of work or name

English

0 references

publication date

1 December 2008

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19050195%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

number of pages

13

1 reference

The Journal of the American Medical Association

inferred from page(s)

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19050195%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

volume

300

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19050195%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

issue

21

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19050195%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

page(s)

2514-2526

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19050195%20AND%20SRC:MED&resulttype=core&format=json

Bioequivalence study of two formulations of enalapril, at a single oral dose of 20 mg (tablets): A randomized, two-way, open-label, crossover study in healthy volunteers

17 January 2020

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2713758

Patients' perceptions of generic medications

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2713758

Brand and generic medications: are they interchangeable?

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2713758

Hospitalization rates of generic metoprolol compared with the original beta-blocker in an epidemiological database study.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2713758

Prescription drug cost sharing: associations with medication and medical utilization and spending and health.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2713758

Interventions to enhance medication adherence in chronic medical conditions: a systematic review.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2713758

Generic substitution: the use of medicinal products containing different salts and implications for safety and efficacy

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2713758

Are brand-name and generic warfarin interchangeable? Multiple n-of-1 randomized, crossover trials

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2713758

Formulation substitution: a frequently overlooked variable in cardiovascular drug management

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2713758

Evaluating non-randomised intervention studies

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2713758

LDL-cholesterol lowering effect of a generic product of simvastatin compared to simvastatin (Zocor) in Thai hypercholesterolemic subjects -- a randomized crossover study, the first report from Thailand

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2713758

Subtherapeutic INR values associated with a switch to generic warfarin

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2713758

Generic substitution: issues for problematic drugs

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2713758

Issues in the use of generic antiarrhythmic drugs

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2713758

Formulation substitution and other pharmacokinetic variability: underappreciated variables affecting antiarrhythmic efficacy and safety in clinical practice

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2713758

Generic antiarrhythmic drugs: what constitutes equivalency

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2713758

Status of generic substitution: problematic drug classes reviewed

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2713758

Generics: what's in a name?

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2713758

Assessing the quality of reports of randomized clinical trials: is blinding necessary?

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2713758

Generic substitution of antiarrhythmic drugs

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2713758

Effect of two formulations of a beta blocker on fibrinolytic response to maximum exercise.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2713758

Therapeutic inequivalence

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2713758

Bioequivalence and tolerability study of two brands of clopidogrel tablets, using inhibition of platelet aggregation and pharmacodynamic measures

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2713758

Bioequivalence. An updated reappraisal addressed to applications of interchangeable multi-source pharmaceutical products.

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2713758

The debate over substitution policy. Its evolution and scientific basis

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2713758

Generic drug substitution revisited

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2713758

Bioequivalence and generic prescribing: a pharmacy view

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2713758

Generic and alternative brand-name pharmaceutical equivalents: select with caution

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2713758

Generic drugs. Therapeutic equivalence

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2713758

Economic implications of evidence-based prescribing for hypertension: can better care cost less?

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2713758

Relevance of pharmacokinetics in narrow therapeutic index drugs

26 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2713758

History and regulatory issues of generic drugs.

26 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2713758

Variable furosemide absorption and poor predictability of response in elderly patients.

26 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2713758

Comparative bio-availability of four formulations of furosemide.

26 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2713758

Comparative bioequivalence study of furosemide in patients with edema of renal origin

26 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2713758

Bioavailability and pharmacokinetics of furosemide marketed in Thailand

26 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2713758

Single-dose, randomized, crossover bioequivalence study of amlodipine maleate versus amlodipine besylate in healthy volunteers

26 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2713758

Results of a phase III, 8-week, multicenter, prospective, randomized, double-blind, parallel-group clinical trial to assess the effects of amlodipine camsylate versus amlodipine besylate in Korean adults with mild to moderate hypertension

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2713758

Disclosure of conflicts of interest by authors of clinical trials and editorials in oncology.

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2713758

Extensions of intellectual property rights and delayed adoption of generic drugs: effects on medicaid spending.

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2713758

Clinical consequences of generic warfarin substitution: an ecological study.

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2713758

Competency profile of locally manufactured clopidogrel Lowplat and foreign manufactured clopidogrel Plavix in patients of suspected ischemic heart disease (CLAP-IHD).

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2713758

Bioequivalence study of two different tablet formulations of carvedilol in healthy volunteers

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2713758

Efficacy and tolerability of the switch from a branded to a generic warfarin sodium product: an observer-blinded, randomized, crossover study

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2713758

Potential savings from increased use of generic drugs in the elderly: what the experience of Medicaid and other insurance programs means for a Medicare drug benefit.

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2713758

Randomized, open-label, two-period crossover comparison of the pharmacokinetic and pharmacodynamic properties of two amlodipine formulations in healthy adult male Korean subjects

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2713758

Efficacy of substituting innovator propafenone for its generic formulation in patients with atrial fibrillation

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2713758

Bioequivalence and other unresolved issues in generic drug substitution

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2713758

Increased warfarin doses and decreased international normalized ratio response after nationwide generic switching

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2713758

Evaluation of the clinical and economic impact of a brand name-to-generic warfarin sodium conversion program

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2713758

A randomized crossover study to evaluate LDL-cholesterol lowering effect of a generic product of simvastatin (Unison Company) compared to simvastatin (Zocor) in hypercholesterolemic subjects.

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2713758

Substitution of generic warfarin for Coumadin in an HMO setting

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2713758

A randomized, crossover comparison of warfarin products in the treatment of chronic atrial fibrillation.

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2713758

Observational cohort study of switching warfarin sodium products in a managed care organization.

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2713758

Effects of food on the bioequivalence of different verapamil sustained-release formulations.

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2713758

Generic warfarin: a cost-effective alternative to brand-name drug or a clinical wild card?

3 September 2018

1 reference

12 December 2020

A comparison of antihypertensive effects between two formulations of atenolol: tenolol and tenormin

1 reference

12 December 2020

Implications of intraindividual variability in bioavailability studies of furosemide

1 reference

12 December 2020

Generic warfarin: implications for patient care

1 reference

12 December 2020

A bioequivalence study of two products of furosemide tablets

1 reference

12 December 2020

Comparative efficacy and bioequivalence of a brand-name and a generic triamterene-hydrochlorothiazide combination product

1 reference

12 December 2020

Comparative bioequivalence study of furosemide in human volunteers

1 reference

12 December 2020

In favor of Coumadin over generic warfarin

1 reference

12 December 2020

The real costs of generic substitution

1 reference

12 December 2020

Generic medicines--can quality be assured?

1 reference

12 December 2020

Myth: generic drugs are lower quality and less safe than brand-name drugs

1 reference

12 December 2020

Effects of branded versus generic terazosin hydrochloride in adults with benign prostatic hyperplasia: a randomized, open-label, crossover study in Taiwan

1 reference

12 December 2020

Conflict of interest in the debate over calcium-channel antagonists

1 reference

12 December 2020

Reflections on generic warfarin

1 reference

12 December 2020

Medical and economic consequences of a blinded oral anticoagulant brand change at a municipal hospital

1 reference

12 December 2020

Efficacy of two proprietary preparations of frusemide in patients with congestive heart failure

1 reference

12 December 2020

Generic substitution--issues relating to the Australian experience

1 reference

12 December 2020

Postabsorption concentration peaks with brand-name and generic verapamil: a double-blind, crossover study in elderly hypertensive patients

1 reference

12 December 2020

Differences in serum concentrations of and responses to generic verapamil in the elderly

1 reference

12 December 2020

Differences in side-effect incidence in patients on proprietary and generic propranolol

1 reference

12 December 2020

Critical therapeutic categories: a contraindication to generic substitution?

1 reference

12 December 2020

Generic substitution and optimal patient care

1 reference

12 December 2020

Generic drug product equivalence: current status

1 reference

12 December 2020

A comparative study of the efficacy of seven brands of frusemide tablets

1 reference

12 December 2020

Once-daily propranolol for hypertension: a comparison of regular-release, long-acting, and generic formulations

1 reference

12 December 2020

The implications of choice: prescribing generic or preferred pharmaceuticals improves medication adherence for chronic conditions

1 reference

12 December 2020

Management of narrow therapeutic index drugs

1 reference

12 December 2020

Comparative bioavailability of two furosemide formulations in humans

1 reference

12 December 2020

Generic warfarin: implications for patient care--another view

1 reference

12 December 2020

Comparable steady-state bioavailability between two preparations of conventional-release procainamide hydrochloride

1 reference

12 December 2020

Identifiers

DOI

10.1001/JAMA.2008.758

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19050195%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19050195%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

PubMed publication ID

19050195

1 reference